HIV-Related Skin Manifestations: Clinical Presentation
Main Article Content
Abstract
Human Immunodeficiency Virus (HIV) infection is associated with a wide spectrum of dermatological manifestations, which often serve as initial indicators of immune dysregulation and disease progression. These cutaneous reactions range from infectious dermatoses, such as viral, bacterial, and fungal infections, to inflammatory and neoplastic conditions, including seborrheic dermatitis, psoriasis, and Kaposi's sarcoma. The underlying pathophysiology of these dermatological reactions is multifactorial, involving direct viral effects, immune suppression, and opportunistic infections. This article provides a comprehensive review of the dermatological reactions observed in HIV-positive patients, emphasizing their clinical presentations, diagnostic approaches, and therapeutic interventions. By understanding the dermatological spectrum of HIV, clinicians can improve early diagnosis, optimize treatment, and enhance the quality of life for affected individuals. The review also highlights the importance of interdisciplinary collaboration in managing these complex dermatological conditions.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Navarrete C, Ortega R, Fich F, Concha M. Manifestaciones dermatológicas asociadas a la infección por VIH/SIA. Rev Chil infectol. 2014; 32: 1-2.
II. Zulueta S, Hecheverria B, Nunez L, Tamayo G. Algunasconsideraciones sobre las afecciones dermatológicasenpacientes.MEDISAN.2017;21:2-3.
III. Organización Mundial de la Salud. OMS [Internet]. 2017 http://www.who.int/mediacentre/factsheets/fs360/es/
IV. Cedeno-Laurent F, Gómez-Flores M, Mendez N, Ancer-Rodríguez J, Bryant JL, Gaspari AA et al. New insights into HIV-1primary skin disorders. J Int AIDS Soc. 2011; 14: 1-3.
V. Pech L, Pérez S, Peralta M. Manifestaciones dermatológicas en pacientes VIH y su correlación con la cantidad de linfocitos CD4 en la clínica de infecciones de transmisión sexual del centro dermatológico. Dermatol Rev Mex. 2014; 58: 6-8.
VI. Boushab BM, Malick Fall FZ, Ould Cheikh Mohamed Vadel TK, Ould Cheikh Melaïnine ML, Maazouz MV, Savadogo M et al. Mucocutaneous manifestations in human immunodeficiency virus (HIV)-infected patients in Nouakchott, Mauritania. Int J 7.-Dermatology [Internet]. 2017; 56: 1-2. https://www.ncbi.nlm.nih.gov/pubmed/28960268.
VII. Bernárdez Y, Curbelo M, Caridad G, Sabatés M, Cabrera M. Afecciones dermatológicas en pacientes con virus de inmunodeficiencia humana. Medisur. 2015; 13: 4-6.
VIII. Foroughi M, Emadi KH, Roosta N, Paydary K, Khatami A, Shahriari S et al. Prevalence of dermatologic manifestations among people living with HIV/AIDS in Imam Khomeini Hospital in Tehran, Iran. Journal of AIDS and HIV. 2012; 4: 57.
IX. Altuntaş Aydin Ö, Kumbasar Karaosmanoğlu H, Korkusuz R, Özeren M, Özcan N. Mucocutaneous manifestations and the relationship to CD4 lymphocyte counts among Turkish HIV/AIDS patients in ?stanbul, Turkey. Turk J Med Sci. 2015; 45: 89-92.
X. Shobhana A, Guha SK, Neogi DK. Mucocutaneous manifestations of HIV infection. Indian J Dermatol Venereol Leprol. 2004; 70: 82-86.
XI. Sud N, Shanker V, Sharma A, Sharma NL, Gupta M. Mucocutaneous manifestations in 150 HIV-infected Indian patients and their relationship with CD4 lymphocyte counts. Int J STD AIDS. 2009; 20: 771-774.
XII. Titou H, Ebongo C, Hjira N. Dermatologic manifestations among human. Int Jl Dematol. 2017; 57: 2-3.
XIII. Prabhakaran N, Telanseri J. Jaisankar, Hamide A, Malathi M, Kumari R. Effect of antiretroviral therapy on mucocutaneous manifestations among Human 15.-Immunodeficiency Virus?infected patients in a tertiary care centre in South India. Indian J Sex Transm Dis AIDS. 2015; 36: 4-8.
XIV. Anand MV, Parimalam K, Nandagopal K. Mucocutaneous manifestations among persons receiving highly active anti-retroviral therapy. Int J Res Dermatol. 2017; 3: 25-128.
XV. Oninla O. Mucocutaneous manifestations of HIV and the correlation with WHO clinical Staging in a Tertiary Hospital in Nigeria. AIDS Research and Treatment. 2014; 2014: 2.